TTP339

Steve Holcombe transitioned from telecom to biotech back when vTv Therapeutics Inc (NASDAQ: VTVT) was just a startup. Now, 18 years in, he’s finally seeing the fruits of his labor. “We’re getting close to the finish line,” Holcombe, the CEO of VTV, told Benzinga. “We...